Schulhoff & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.36M | Buy |
48,562
+60
| +0.1% | +$1.6K | 0.56% | 46 |
|
|
2025
Q4 | $1.21M | Sell |
48,502
-970
| -2% | -$24.5K | 0.51% | 49 |
|
|
2025
Q3 | $1.26M | Buy |
49,472
+61
| +0.1% | +$1.51K | 0.54% | 48 |
|
|
2025
Q2 | $1.2M | Buy |
49,411
+3,213
| +7% | +$74.9K | 0.53% | 46 |
|
|
2025
Q1 | $1.17M | Sell |
46,198
-602
| -1% | -$15.8K | 0.52% | 46 |
|
|
2024
Q4 | $1.24M | Sell |
46,800
-4,536
| -9% | -$123K | 0.45% | 47 |
|
|
2024
Q3 | $1.49M | Sell |
51,336
-7,852
| -13% | -$229K | 0.62% | 42 |
|
|
2024
Q2 | $1.66M | Sell |
59,188
-158
| -0.3% | -$4.35K | 0.75% | 36 |
|
|
2024
Q1 | $1.65M | Buy |
59,346
+50
| +0.1% | +$1.39K | 0.72% | 39 |
|
|
2023
Q4 | $1.71M | Buy |
59,296
+2,637
| +5% | +$79.7K | 0.81% | 35 |
|
|
2023
Q3 | $1.88M | Sell |
56,659
-456
| -0.8% | -$16.1K | 0.95% | 26 |
|
|
2023
Q2 | $2.09M | Buy |
57,115
+84
| +0.1% | +$3.27K | 0.97% | 29 |
|
|
2023
Q1 | $2.33M | Buy |
57,031
+31
| +0.1% | +$1.34K | 1.08% | 25 |
|
|
2022
Q4 | $2.92M | Sell |
57,000
-2,580
| -4% | -$124K | 1.34% | 21 |
|
|
2022
Q3 | $2.61M | Buy |
59,580
+23
| +0% | +$1.12K | 1.36% | 22 |
|
|
2022
Q2 | $3.12M | Sell |
59,557
-84
| -0.1% | -$4.28K | 1.46% | 22 |
|
|
2022
Q1 | $3.09M | Sell |
59,641
-131
| -0.2% | -$6.8K | 1.3% | 24 |
|
|
2021
Q4 | $3.53M | Sell |
59,772
-425
| -0.7% | -$21.1K | 1.45% | 23 |
|
|
2021
Q3 | $2.59M | Buy |
60,197
+3
| +0% | +$133 | 1.17% | 25 |
|
|
2021
Q2 | $2.36M | Buy |
60,194
+188
| +0.3% | +$7.31K | 1.04% | 29 |
|
|
2021
Q1 | $2.17M | Buy |
60,006
+626
| +1% | +$22.2K | 0.99% | 29 |
|
|
2020
Q4 | $2.19M | Sell |
59,380
-3,340
| -5% | -$123K | 1.1% | 27 |
|
|
2020
Q3 | $2.18M | Buy |
62,720
+777
| +1% | +$27.2K | 1.17% | 28 |
|
|
2020
Q2 | $1.92M | Buy |
61,943
+26
| +0% | +$883 | 1.13% | 28 |
|
|
2020
Q1 | $1.92M | Buy |
61,917
+637
| +1% | +$21.7K | 1.2% | 26 |
|
|
2019
Q4 | $2.28M | Buy |
61,280
+231
| +0.4% | +$8.23K | 1.07% | 29 |
|
|
2019
Q3 | $2.08M | Sell |
61,049
-1,931
| -3% | -$70.2K | 1.02% | 28 |
|
|
2019
Q2 | $2.59M | Buy |
62,980
+649
| +1% | +$25.8K | 1.33% | 22 |
|
|
2019
Q1 | $2.51M | Buy |
62,331
+2,278
| +4% | +$91.2K | 1.34% | 21 |
|
|
2018
Q4 | $2.49M | Sell |
60,053
-301
| -0.5% | -$12.5K | 1.55% | 18 |
|
|
2018
Q3 | $2.52M | Buy |
60,354
+1,070
| +2% | +$41.2K | 1.41% | 21 |
|
|
2018
Q2 | $2.04M | Buy |
59,284
+118
| +0.2% | +$4.03K | 1.21% | 26 |
|
|
2018
Q1 | $1.99M | Sell |
59,166
-299
| -0.5% | -$10.3K | 1.17% | 26 |
|
|
2017
Q4 | $2.04M | Buy |
59,465
+123
| +0.2% | +$4.19K | 1.15% | 25 |
|
|
2017
Q3 | $2.01M | Sell |
59,342
-50
| -0.1% | -$1.61K | 1.19% | 22 |
|
|
2017
Q2 | $1.89M | Sell |
59,392
-193
| -0.3% | -$6.09K | 1.16% | 23 |
|
|
2017
Q1 | $1.93M | Buy |
59,585
+939
| +2% | +$29.6K | 1.19% | 21 |
|
|
2016
Q4 | $1.81M | Sell |
58,646
-8,518
| -13% | -$260K | 1.11% | 24 |
|
|
2016
Q3 | $2.16M | Sell |
67,164
-3,778
| -5% | -$126K | 1.33% | 19 |
|
|
2016
Q2 | $2.37M | Buy |
70,942
+944
| +1% | +$30.1K | 1.47% | 19 |
|
|
2016
Q1 | $1.97M | Buy |
69,998
+790
| +1% | +$22.6K | 1.29% | 23 |
|
|
2015
Q4 | $2.12M | Sell |
69,208
-922
| -1% | -$29K | 1.44% | 21 |
|
|
2015
Q3 | $2.09M | Sell |
70,130
-5,794
| -8% | -$186K | 1.5% | 20 |
|
|
2015
Q2 | $2.42M | Sell |
75,924
-656
| -0.9% | -$21.4K | 1.54% | 20 |
|
|
2015
Q1 | $2.53M | Buy |
76,580
+17
| +0% | +$540 | 1.57% | 18 |
|
|
2014
Q4 | $2.26M | Buy |
76,563
+468
| +0.6% | +$13.4K | 1.36% | 21 |
|
|
2014
Q3 | $2.13M | Buy |
76,095
+283
| +0.4% | +$7.94K | 1.33% | 21 |
|
|
2014
Q2 | $2.13M | Sell |
75,812
-273
| -0.4% | -$7.78K | 1.32% | 21 |
|
|
2014
Q1 | $2.32M | Sell |
76,085
-117
| -0.2% | -$3.49K | 1.57% | 19 |
|
|
2013
Q4 | $2.21M | Sell |
76,202
-169
| -0.2% | -$4.92K | 1.51% | 17 |
|
|
2013
Q3 | $2.08M | Sell |
76,371
-3,146
| -4% | -$85.6K | 1.5% | 18 |
|
|
2013
Q2 | $2.11M | Buy |
+79,517
| New | +$2.2M | 1.59% | 17 |
|
Other funds holding PFE
VCM
VPM
Schulhoff & Co's PFE Position: Q1 2026 in Review
Schulhoff & Co increased its Pfizer (PFE) stake by 0.12% in Q1 2026, buying an estimated $1.6K and bringing the position to 48,562 shares worth $1.36M. The position accounts for 0.56% of the portfolio, ranked #46.
Schulhoff & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.53M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Schulhoff & Co held 48,562 shares of Pfizer worth $1.36M as of Q1 2026.
- Schulhoff & Co bought 60 Pfizer shares in Q1 2026, an estimated $1.6K.
- Pfizer made up 0.56% of Schulhoff & Co's portfolio in Q1 2026, its #46 holding.
- Schulhoff & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Schulhoff & Co's Pfizer position peaked at $3.53M in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Schulhoff & Co's 13F filing for Q1 2026, filed 11 May 2026.